Detalhe da pesquisa
1.
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.
BMC Cancer
; 22(1): 908, 2022 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986318
2.
Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study.
Br J Cancer
; 125(6): 798-805, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211120
3.
Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review.
BMC Cancer
; 21(1): 43, 2021 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422020
4.
Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
Dig Dis Sci
; 66(6): 1965-1973, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734400
5.
Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study.
Cancer Causes Control
; 31(1): 1-11, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786674
6.
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
BMC Cancer
; 20(1): 500, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487090
7.
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Gut
; 68(11): 1918-1927, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852560
8.
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Int J Cancer
; 145(12): 3389-3401, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050820
9.
High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study.
Histopathology
; 74(4): 587-596, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408225
10.
Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.
Br J Cancer
; 117(2): 203-209, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28595259
11.
The Impact of the COVID-19 Pandemic on Barrett's Esophagus and Esophagogastric Cancer.
Gastroenterology
; 160(6): 2169-2171.e1, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513406
12.
Response to: 'Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma' by Li.
Gut
; 70(3): 626, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32606210
13.
The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis.
Cell Death Dis
; 15(1): 40, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216558
14.
Real world outcomes in cancer patients with COVID-19 infection: Northern Ireland experience.
Ulster Med J
; 92(1): 29-37, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762131
15.
Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis.
PLoS One
; 18(8): e0289355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527282
16.
Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series.
BMC Sports Sci Med Rehabil
; 15(1): 116, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735664
17.
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.
J Clin Oncol
; 41(10): 1943-1948, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603179
18.
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.
J Clin Oncol
; 41(28): 4522-4534, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499209
19.
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Lancet Gastroenterol Hepatol
; 8(11): 1015-1027, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734399
20.
The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis.
Cancer Epidemiol Biomarkers Prev
; 31(5): 1090-1102, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34810209